Sign in

You're signed outSign in or to get full access.

Lance Wilson

Chief Financial Officer at T Stamp
Executive

About Lance Wilson

Lance Wilson is Chief Financial Officer of T Stamp Inc. (Trust Stamp), appointed January 17, 2025, with an Executive Employment Agreement effective January 1, 2025; he is 35 years old, a licensed CPA in Georgia, and holds a Master of Accountancy and a BS from The University of Alabama . His background includes leading external financial reporting and SEC compliance at Trust Stamp since 2021, contributing to the company’s Nasdaq listing in January 2022, and prior roles in public company financial reporting at Cousins Properties and earlier accounting roles at North Highland, Change Healthcare, and BDO USA . Compensation is structured as salary plus an annual equity bonus in RSUs with criteria set annually by the Board; his agreement provides open-ended term with 120 days’ notice and severance of up to 36 months’ base salary in certain terminations, with accelerated vesting in some circumstances including change in control .

Past Roles

OrganizationRoleYearsStrategic Impact
T Stamp Inc. (Trust Stamp)Senior Vice President of Accounting & FinanceJul 2024 – Jan 2025Led accounting/finance prior to CFO appointment, overseeing SEC reporting and investor relations preparation .
T Stamp Inc. (Trust Stamp)Finance Reporting ManagerJul 2021 – Jul 2024Established financial reporting function; pivotal in Nasdaq listing in Jan 2022 .
Cousins Properties (NYSE: CUZ)Financial Reporting ManagerJul 2020 – Jul 2021Managed SEC filings and technical accounting projects at a public REIT .
The North Highland CompanyAccounting rolesNot disclosedEarly-career accounting roles contributing to technical accounting experience .
Change Healthcare (formerly McKesson Technology Solutions)Accounting rolesNot disclosedAccounting roles in healthcare technology operations .
BDO USA, LLCPublic AccountingNot disclosedPublic accounting foundation; licensed CPA in Georgia .

External Roles

No external public company directorships or committee roles for Wilson are disclosed in Company filings reviewed (biography and executive officer sections) .

Fixed Compensation

ComponentAmount/TermsEffective DateNotes
Base Salary$182,250 annualJan 1, 2025Subject to periodic review under Executive Employment Agreement .
TermOpen-endedJan 1, 2025Either party may terminate with 120 days’ written notice .
Benefits/ExpensesCompany benefit plans; business expense reimbursement; relocation assistance if applicableJan 1, 2025Standard provisions in agreement .

Performance Compensation

Incentive TypeMetric(s)WeightingTargetActual/PayoutForm & Vesting
Annual Equity Bonus (RSUs)Criteria established annually by BoardNot disclosedNot disclosedAt least 10% of base salary (equity bonus eligibility floor)Paid in RSUs; specific vesting for Wilson not disclosed; company practice has executive RSU awards vest January 2 of following year (e.g., 2023 awards vested Jan 2, 2024; 2024 awards granted in 2025 vest Jan 2, 2026) .

The Company states it does not maintain a formal equity incentive plan; RSUs are awarded as stock bonuses determined by the Board .

Equity Ownership & Alignment

Date (As Of)Shares Owned (Direct/Indirect)RSUs/Acquirable Within 60 DaysTotal Beneficial Ownership %
Mar 28, 20259590.02%
Sep 30, 20259282,637 (RSUs “issuable at any time upon request”)0.05%
  • Pledging/hedging: Company policy prohibits hedging transactions in Company securities; no specific pledging by Wilson is disclosed in filings reviewed .
  • Ownership guidelines: No executive stock ownership guidelines for Wilson are disclosed in filings reviewed .
  • Insider reporting: Company indicates Section 16(a) compliance by executive officers in 2021–2025 to date, based on its review of filings (one late Form 3 by a 10% holder noted; no exceptions named for Wilson) .

Employment Terms

TermDetail
AppointmentAppointed CFO on January 17, 2025 (Agreement effective January 1, 2025) .
Salary$182,250 annual base salary, subject to review .
Annual BonusEligibility for annual equity bonus of at least 10% of base salary, paid in RSUs, subject to Board-established criteria and continued employment through payment date .
Termination NoticeOpen-ended term; 120 days’ written notice by either party .
SeveranceIf terminated without cause or resigns for good reason: severance up to 36 months of base salary; also provides for accelerated vesting of equity awards in certain circumstances, including change in control (specific triggers not detailed in summary) .
OtherConfidentiality and nondisclosure provisions included .

Investment Implications

  • Pay-for-performance alignment: Wilson’s incentive pay is primarily RSU-based with only a 10% minimum equity bonus floor—lower than peers in the same proxy who target 50–100%—which limits upside leverage but aligns him with equity value; specific performance metrics and weightings are not disclosed, reducing transparency of pay-performance linkage .
  • Vesting/selling pressure: Beneficial ownership shows 2,637 RSUs “issuable at any time upon request,” implying immediate settlement capacity and incremental supply risk near blackout expirations; absence of disclosed pledging and hedging prohibition mitigates alignment concerns .
  • Retention and change-in-control risk: Open-ended term with a 120-day notice is flexible, but severance “up to 36 months” base salary and accelerated vesting in certain circumstances (including change in control) represent materially protective terms that could increase cost of transition and potentially create negotiation leverage for the executive (single vs. double-trigger not specified in the summary) .
  • Ownership alignment: As of September 30, 2025, Wilson’s stake is modest at 0.05% (928 owned; 2,637 acquirable RSUs), offering some alignment but limited governance influence; the Company does not disclose stock ownership guidelines for executives .
  • Execution capability: His background in SEC reporting and technical accounting, including prior public REIT reporting and leading Trust Stamp’s listing process, signals strong execution in financial reporting and compliance—supportive for credibility with regulators and investors during financing and listing compliance processes .